Skip to content

To study the role of Madhukadi taila Nasya kriyakalpa in management of Vataja Pratishaya(Allergic rhinitis)

Effectiveness of Madhukadi Tail Nasya in comparison with Xylometazoline 0.1 percent Hydrochloride nasal spray in the Management of Vataja Pratishaya(Allergic rhinitis)-A Randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080786
Enrollment
84
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Dr Bhagyashri Telgote
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18 yrs to 45yrs. 2. All genders and socioeconomic class. 3.Patients having sign and symptoms of Vataj Pratishaya ( Allergic rhinitis) mentioned in classic and modern text.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Patients having known case of TB ,ASTHMA,COPD,Malignancy. 3.Patients who need surgical & other intervention(polyp,etc.) 4.Patients having perforated Tympanic membrane.

Design outcomes

Primary

MeasureTime frame
To study the effect of Madhukadi Tail Nasya in reducing the symptoms like Aanadha pihita nasa,Tanustrav pravartini,Gala,Talu,Osthashosha,Shirshool,Swaropghat,Bhrush Kshwa Timepoint: Follow up on 0th,7th,14th,21thday

Secondary

MeasureTime frame
To assess the effect of Madhukadi Tail nasya on Absolute Eosinophillic Count And Erythrocyte Sedimentation RateTimepoint: Follow up on 0th,7th,14th,21thday

Countries

India

Contacts

Public ContactDr Sunita Magar

YMT Ayurvedic Medical College and Hospital

sunitamagar66@gmail.com9987335024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026